Cargando…
Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in England
BACKGROUND: Trials of novel agents are required to improve the care of patients with rare diseases, but trial feasibility may be uncertain due to concerns over insufficient patient numbers. We aimed to determine the size of the pool of potential participants in England 2015–2017 for trials in the au...
Autores principales: | Persson, M. S. M., Harman, K. E., Thomas, K. S., Chalmers, J. R., Vinogradova, Y., Langan, S. M., Hippisley-Cox, J., Gran, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863423/ https://www.ncbi.nlm.nih.gov/pubmed/33541270 http://dx.doi.org/10.1186/s12874-021-01212-1 |
Ejemplares similares
-
Validation study of bullous pemphigoid and pemphigus vulgaris recording in routinely collected electronic primary healthcare records in England
por: Persson, Monica S M, et al.
Publicado: (2020) -
Long-term oral prednisolone exposure in primary care for bullous pemphigoid: population-based study
por: Persson, Monica SM, et al.
Publicado: (2021) -
Molecular Diagnosis in Autoimmune Skin Blistering Conditions
por: Otten, J.V., et al.
Publicado: (2014) -
Skin Barrier and Autoimmunity—Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin
por: Stevens, Natalie E., et al.
Publicado: (2019) -
Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases
por: Olbrich, Michael, et al.
Publicado: (2019)